newwin
Luciann Nguyen
Settings
← Accounts
biotech

QIAGEN Gaithersburg, Inc

46
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

QIAGEN Gaithersburg, Inc

New trial — DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

New trialNCT06645236
46/100
Opportunity
Commercial fit11/25
Clinical timing11/20
Biomarker need5/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New not applicable trial NCT06645236 posted by QIAGEN Gaithersburg, Inc: "DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit". New trial on a not applicable recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 389 days ago.

ConfidenceHigh · 87%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT06645236
DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
not applicable
mol. elig.